Alp Invest Partners B.V. Gritstone Bio, Inc. Transaction History

Alp Invest Partners B.V.

  • $140 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$6.41 - $13.54 $833,261 - $1.76 Million
-129,994 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$8.13 - $10.2 $787,569 - $988,094
-96,872 Reduced 42.7%
129,994 $1.19 Million
Q1 2021

May 14, 2021
BUY
$4.07 - $27.11 $923,344 - $6.15 Million
226,866 New
226,866 $2.14 Million

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Alp Invest Partners B.V. Portfolio

Follow Alp Invest Partners B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

News

Stay updated on Alp Invest Partners B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email